Elevate Capital Advisors »

Dyne Therapeutics shares owned by Elevate Capital Advisors

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Elevate Capital Advisors from 13F filings

Historical chart of Elevate Capital Advisors investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Elevate Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Elevate Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $472k 24k 19.56

More positions owned by Elevate Capital Advisors

Ishares Tr Ishs 1-5yr Invs (IGSB)
Sprott Asset Management Physical Gold Tr (PHYS)
Travelers Companies (TRV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Apple (AAPL)
Microsoft Corporation (MSFT)
Hershey Company (HSY)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
W.R. Berkley Corporation (WRB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Series Trust State Street Spd (BIL)
Franco-Nevada Corporation (FNV)

View all positions for Elevate Capital Advisors

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
State Street Corporation
Fcpm Iii Services B.v.
FMR
Orbis Allan Gray
TCG Crossover Management
Adage Capital Partners GP
Siren
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Dyne Therapeutics